Testing effectiveness (Phase 2)Study completedNCT00065156
What this trial is testing
Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenetic Abnormality
Who this might be right for
Myelodysplastic Syndromes
Celgene 148